Prime Medicine Inc (NASDAQ: PRME) is -54.45% lower on its value in year-to-date trading and has touched a low of $1.12 and a high of $8.27 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PRME stock was last observed hovering at around $1.17 in the last trading session, with the day’s gains setting it 0.16%.
Currently trading at $1.33, the stock is -22.17% and -38.89% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.74 million and changing 13.68% at the moment leaves the stock -62.13% off its SMA200. PRME registered -77.42% loss for a year compared to 6-month loss of -62.64%. The firm has a 50-day simple moving average (SMA 50) of $2.1764 and a 200-day simple moving average (SMA200) of $3.512325.
The stock witnessed a -22.67% gain in the last 1 month and extending the period to 3 months gives it a -54.76%, and is -5.67% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 17.26% over the week and 11.84% over the month.
Prime Medicine Inc (PRME) has around 214 employees, a market worth around $174.44M and $2.98M in sales. Profit margin for the company is -6566.61%. Distance from 52-week low is 19.28% and -83.92% from its 52-week high. The company has generated returns on investments over the last 12 months (-102.92%).
with sales reaching $3.43M over the same period.The EPS is expected to grow by 27.26% this year, but quarterly earnings will post 560.21% year-over-year. Quarterly sales are estimated to grow 480.77% in year-over-year returns.
Prime Medicine Inc (PRME) Top Institutional Holders
171.0 institutions hold shares in Prime Medicine Inc (PRME), with institutional investors hold 77.65% of the company’s shares. The shares outstanding are 131.16M, and float is at 51.92M with Short Float at 35.25%. Institutions hold 59.09% of the Float.
The top institutional shareholder in the company is ALPHABET INC. with over 15.06 million shares valued at $77.42 million. The investor’s holdings represent 12.6375% of the PRME Shares outstanding. As of 2024-06-30, the second largest holder is ARK INVESTMENT MANAGEMENT LLC with 6.13 million shares valued at $31.49 million to account for 5.1404 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 5.11 million shares representing 4.2877% and valued at over $26.27 million, while FMR LLC holds 3.2955 of the shares totaling 3.93 million with a market value of $20.19 million.
Prime Medicine Inc (PRME) Insider Activity
#####
